A supply concentration is a reserve risk before it is a headline. Mobileye's IPO prospectus, the Form 424B4 filed October 27, 2022, introduces public investors to a company whose product is the EyeQ system-on-chip — the silicon that powers advanced driver-assistance systems in tens of millions of vehicles. The same prospectus is candid about the exposure beneath that franchise: Mobileye states it is substantially reliant on timely shipments of EyeQ SoCs from STMicroelectronics, the foundry partner that manufactures the chips.
For the markets desk, single-source dependency is a classic concentration risk, and it is worth pricing rather than waving away. The EyeQ family — including the EyeQ5 and forthcoming EyeQ6, with the EyeQ Ultra positioned as an AV-grade chip — is the product. If the manufacturing of that product runs through one partner, then Mobileye's ability to fulfill design wins, recognize revenue, and hold customers is hostage to that partner's capacity, yields, and priorities. A semiconductor shortage, a fab disruption, or a reallocation of capacity becomes Mobileye's revenue problem.
The customer side compounds it. Mobileye's revenue is concentrated among a set of large automotive OEM customers, which means the business has concentration on both ends — a narrow supply base feeding a narrow set of high-volume buyers. The prospectus discloses inventory of EyeQ SoCs on hand as a partial buffer, which is itself a tell: holding chip inventory is the company managing the very dependency it discloses.
The Intel relationship adds a layer worth reading carefully. Mobileye is being carved out of Intel via this offering, and the prospectus details the ongoing ties — governance, shared technology roadmaps, and the foundry arrangements — that shape how independent the new public company really is. A risk reader should treat the parent relationship as part of the structural picture, not a footnote.
The forward question from October 2022: does Mobileye diversify its foundry exposure and broaden its customer base fast enough to de-risk the franchise, or does the EyeQ supply chain remain the single point of failure under a high-multiple ADAS story? The IPO sells the design-win momentum; the prospectus discloses the dependency that momentum runs through.
This analysis is grounded in Mobileye Global's IPO prospectus (Form 424B4) as filed with the SEC and surfaced via EdgarBeast, the SEC filing data API and evidence index. The primary document is the filing.